New UCF Nanotech Gives Boost to Detection of Cancer and Disease
The technique uses nickel-platinum nanoparticles to increase the sensitivity of an enzyme-linked immunosorbent assay, or ELISA, that is used to test for the presence of cancers, HIV and more
Early screening can mean the difference between life and death in a cancer and disease diagnosis. That’s why University of Central Florida researchers are working to develop a new screening technique that’s more than 300 times as effective at detecting a biomarker for diseases like cancer than current methods.
The technique, which was detailed recently in the Journal of the American Chemical Society, uses nanoparticles with nickel-rich cores and platinum-rich shells to increase the sensitivity of an enzyme-linked immunosorbent assay (ELISA).
ELISA is a test that measures samples for biochemicals, such as antibodies and proteins, which can indicate the presence of cancer, HIV, pregnancy and more. When a biochemical is detected, the test generates a color output that can be used to quantify its concentration. The stronger the color is, the stronger the concentration. The tests must be sensitive to prevent false negatives that could delay treatment or interventions.
In the study, the researchers found that when the nanoparticles were used in place of the conventional enzyme used in an ELISA — peroxidase — that the test was 300 times more sensitive at detecting carcinoembryonic antigen, a biomarker sometimes used to detect colorectal cancers.
And while a biomarker for colorectal cancer was used in the study, the technique could be used to detect biomarkers for other types of cancers and diseases, says Xiaohu Xia, an assistant professor in UCF’s Department of Chemistry and study co-author.
Colorectal cancer is the third leading cause of cancer-related deaths in the U.S., not counting some kinds of skin cancer, and early detection helps improve treatment outcomes, according to the U.S. Centers for Disease Control and Prevention.
The increase in sensitivity comes from nickel-platinum nanoparticle “mimics” that greatly increase the reaction efficiency of the test, which increases its color output, and thus its detection ability, Xia says.
Peroxidases found in the horseradish root have been widely used to generate color in diagnostic tests for decades. However, they have limited reaction efficiency and thus color output, which has inhibited the development of sensitive diagnostic tests, Xia says.
Nanoparticle “mimics” of peroxidase have been extensively developed over the past 10 years, but none have achieved the reaction efficiency of the nanoparticles developed by Xia and his team.
“This work sets the record for the catalytic efficiency of peroxidase mimic,” Xia says. “It breaks through the limitation of catalytic efficiency of peroxidase mimics, which is a long-standing challenge in the field.”
“Such a breakthrough enables highly sensitive detection of cancer biomarkers with the ultimate goal of saving lives through earlier detection of cancers,” he says.
Xia says next steps for the research are to continue to refine the technology and apply it to clinical samples of human patients to study its performance.
“We hope the technology can be eventually used in clinical diagnostic laboratories in the near future,” Xia says.
Original Article: New UCF Nanotech Gives Boost to Detection of Cancer and Disease
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Enzyme-linked immunosorbent assay
- Multicolorimetric ELISA biosensors on a paper/polymer hybrid analytical device for visual point-of-care detection of infection diseases.on April 28, 2021 at 10:16 pm
Enzyme-linked immunosorbent assay (ELISA) is widely used for the detection of disease biomarkers. However, it utilizes time-consuming procedures and expensive instruments, making it infeasible for ...
- Oxidative Stress Assay Market Worth $ 1676.14 Million, Globally, by 2028 at 9.51% CAGR: Verified Market Research(TM)on April 23, 2021 at 8:56 am
2020-2027 Enzyme-Linked Immunosorbent Assay (ELISA) Market by Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA), by Application (Cancer, HIV AIDS, Inflammation Disorders, Protein Quantification ...
- A novel method for the storage and transport of biological samples of therapeutic proteins prior to the detection of analytes using ELISAon April 22, 2021 at 4:41 am
Therapeutic proteins have exhibited promising clinical applications in the diagnosis and treatment of some diseases. Prior to the detection of analytes using enzyme-linked immunosorbent assay, ...
- Can fingerprick blood tests help evaluate antibody response and longevity against SARS-CoV-2 post-vaccination?on April 20, 2021 at 5:36 am
To monitor antibody level duration of vaccine-induced immune responses, a team of researchers in the U.S. – at Diacarta, University of California and VA Healthcare System, and the Franciscan ...
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopeniaon April 17, 2021 at 5:36 am
In almost every patient, high levels of antibodies to platelet factor 4 (PF4)–polyanion complexes were identified by enzyme-linked immunosorbent assay (ELISA), as well by assays based on platelet ...
Go deeper with Google Headlines on:
Enzyme-linked immunosorbent assay
Go deeper with Bing News on:
Detection of cancer biomarkers
- Lab on a chip for multiplexed immunoassays to detect bladder cancer using multifunctional dielectrophoretic manipulationson April 30, 2021 at 12:14 pm
A multiplexed immunosensor has been developed for the detection of specific biomarkers Galectin-1 (Gal-1) and Lactate Dehydrogenase B (LDH-B) present in different grades of bladder cancer cell lysates ...
- Raman Spectroscopy-Based Quality Control of "Silicon-On-Insulator" Nanowire Chips for the Detection of Brain Cancer-Associated MicroRNA in Plasma.on April 28, 2021 at 10:19 pm
Application of micro-Raman spectroscopy for the monitoring of quality of nanowire sensor chips fabrication has been demonstrated. Nanowire chips have been fabricated on the basis of ...
- Novel platform has potential to detect many disease-related biomarkers in just one teston April 27, 2021 at 9:46 pm
Most conventional molecular diagnostics usually detect only a single disease-related biomarker. Great examples are the PCR tests currently used to diagnose COVID-19 by detecting a specific sequence ...
- DNA tetrahedron-mediated immune-sandwich assay for rapid and sensitive detection of PSA through a microfluidic electrochemical detection systemon April 24, 2021 at 5:01 pm
Prostate-specific antigen (PSA) is the most widely used biomarker for the early diagnosis of prostate cancer. Existing methods for PSA detection are burdened with some limitations and require ...
- Global Molecular Biomarkers for Cancer Detection and Management Market Size, Share, Value, and Competitive Landscape forecast year 2021-2026on April 22, 2021 at 11:37 pm
The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market ...